Selected conference presentations, invited lectures, and webinars addressing health technology assessment, health policy, market access, real-world evidence, and patient engagement.
Scientific Conferences & Academic Contributions
Scientific presentations, methodological discussions and contributions to international research conferences.
- Gilardino, R. E. (2026, June 10). Highlights From IJTAHC On Patient And Stakeholder Engagement As A Drive For Shaping Health Systems. HTAi 2026 Annual Meeting, Istanbul, Türkiye. Panel.
- Gilardino, R. E. (2026, May). From Engagement to Influence: What Should Patient-Centered Economic Models Actually Look Like?. ISPOR 2026, Philadelphia, United States. Issue panel.
- Gilardino, R. (2026, May). Beyond the Bots: How AI-Enabled Literature Reviews Are Maturing, and What HEOR Needs Next. ISPOR 2026, Philadelphia, United States.
- Gilardino, R. (2026, May). Advancing Patient-Centered Health Technology Assessment to Strengthen Equity and Transparency in Latin American Health Systems. ISPOR 2026, Philadelphia, United States.
- Gilardino, R. (2025, November). Battle of the Bots: Navigating the Landscape of AI-Enabled Systematic Literature Review Platforms. ISPOR Europe 2025, Glasgow, Scotland.
- Gilardino, R. E. (2025, June). Patient engagement in economic modeling. HTAi 2025 Annual Meeting, Buenos Aires, Argentina. Panel.
- Gilardino, R. E. (2025, June). Operationalizing lifecycle health technology assessment. HTAi 2025 Annual Meeting, Buenos Aires, Argentina. Panel.
- Gilardino, R. (2025, May). Leveraging Automated Tools for Literature Reviews in Health Economics and Outcomes Research: Opportunities, Challenges, and Best Practices. ISPOR 2025, Montreal, Canada.
- Gilardino, R. (2024, November). From methods to implementation: Real-world and regulatory applications of patient experience data through patient experience mapping & patient involvement. ISPOR Europe 2024, Barcelona, Spain.
- Gilardino, R. (2024, November). Role of real-world evidence and artificial intelligence in accelerated approvals in oncology: Current status and next steps. ISPOR Europe 2024, Barcelona, Spain.
- Gilardino, R. (2024, November). Can generative AI aid readiness for Joint Clinical Assessment (JCA)?. ISPOR Europe 2024, Barcelona, Spain.
- Gilardino, R. (2024, June 27). 20 years of the Global Policy Forum: Providing value to HTAi members and the wider HTA community. HTAi 2024 Annual Meeting, Seville, Spain.
- Gilardino, R. (2023, June 27). Equity in health technology assessment: Approaches to incorporate equity into healthcare decision making. HTAi 2023 Annual Meeting, Adelaide, Australia. Lecture.
- Gilardino, R. (2022, November 7). Are open-source models really for health technology assessment and health policy?. ISPOR Europe, Vienna, Austria. Lecture.
- Gilardino, R. (2022, June 27). Would novel elements of value contribute to equitable access to medical technologies?. HTAi 2022 Annual Meeting, Utrecht, Netherlands. Lecture.
Policy, Industry & Stakeholder Forums
Cross-sector discussions on health policy, access, innovation and stakeholder engagement.
- Gilardino, R. E. (2026, September 25). Patient-led Approaches to Real-World Data Collection, Analysis & Usage. EUPATI Annual Assembly 2026. Panel discussion.
- Gilardino, R. E. (2026, June 3). Patient Engagement & Environment Shaping: Developing Strategies to Influence the Factors That Determine Real-World Access. Patient Engagement Open Forum 2026, Seville, Spain. Panel discussion.
- Gilardino, R. E. (2026, June 2). Shaping patient-centered HTA policy: Multi-stakeholder priorities for value-driven consensus. Patient Engagement Open Forum 2026, Seville, Spain. Panel discussion.
- Gilardino, R. E. (2026, March). The Dynamics of Drug Shortages in Europe: Sustainable Pricing for Post-LOE Products. World Evidence, Pricing & Access Congress, Amsterdam.
- Gilardino, R. E. (2025, March). Bridging the Gaps: From Innovation to Adoption. World Evidence, Pricing & Access Congress, Amsterdam. Interactive panel.
- Gilardino, R. E. (2024, April). Foster Collaboration on all Fronts to Deliver Timely Access to Medicine and Biomarker Testing. Reuters Events: Pharma, Barcelona, Spain. Panelist.
- Gilardino, R. E. (2024, March). Value-Based Pricing and Innovative Approaches to Market Access. World Evidence, Access and Pricing Congress, Amsterdam. Interactive panel.
- Ciani, O., & Gilardino, R. E. (2023, November). Healthcare system benefits of improving patient access to early-stage cancer treatments in Europe. ISPOR Europe, Copenhagen, Denmark.
- Gilardino, R. E. (2023, April). Industry preparedness for the EU Joint Clinical Assessment (JCA). Reuters Events: Pharma, Barcelona, Spain. Panelist.
- Gilardino, R. E. (2023, March 22). HTA track, Day 2. World Evidence, Access and Pricing Congress. Chair.
- Gilardino, R. (2022). Utilizing RWE and HEOR throughout the product lifecycle: From product positioning to market access and reimbursement. ISPOR 2022, Washington, D.C., USA. Lecture.
Education, Training & Webinars
Invited interviews, educational webinars and professional training.
- Gilardino, R. E. (2026, October 29). Patient Engagement in HTA. EUPATI Patient Expert Training Program – Cohort 9 Fall Event. Speaker · Sitges . Event details.
- Gilardino, R. E. (2026, October 15). Patient Engagement in Market Access & HTA Activities. EUPATI Switzerland Online Training “Market Access, HTA & Policy” . Speaker · Virtual. Event details.
- Gilardino, R. E. (2026, September 23). Closing the Standards Gap: Rethinking AI Evaluation Frameworks for HEOR Evidence Generation. Speaker. Event details.
- Gilardino, R. E. (2026, September). Real World Data and Real World Evidence. EUPATI PETP, Cohort 9. Webinar.
- Gilardino, R. E. (2026, January). Patti’s People: Patti Peeples speaks with Ramiro Gilardino. Becaris Publishing. Interview. Event details.
- Gilardino, R. E. (2025, October 8). Defining Patient-Centered Access to Improve Health Outcomes. Speaker · Online. Event details.
- Gilardino, R. E. (2025, September 16). Why Serve on the ISPOR Board? Hear From ISPOR Leaders. Speaker · Online. Event details.